Back to company

LICA PHARMACEUTICALS ApS: Financial statements 2017

CVR: 25332520

LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 408,690 and a net result of DKK 812,469 compared with DKK 327,524 the year before. That is a decrease of 44.6% compared with the year before. Equity amounted to DKK 12,795,456. The solvency ratio was 99.2%.

Gross Profit
408,690 kr.
Profit/Loss
812,469 kr.
Equity
12,795,456 kr.
Total Assets
12,897,633 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-409 t.812 t.12.8 mio.-
2016-738 t.328 t.12 mio.-
2015-312 t.-2.3 mio.11.7 mio.-
2014-269 t.3.9 mio.13.9 mio.-
2013-341 t.783 t.10 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like LICA PHARMACEUTICALS ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

LICA PHARMACEUTICALS ApS: The 2016 annual report is outMay 5, 2017

LICA PHARMACEUTICALS ApS has published its annual report for 2016. Gross profit came to DKK 737,979, and the net result was DKK 327,524.

About LICA PHARMACEUTICALS ApS

LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The management consists of Arsalan Kharazmi. The company is owned by Arsalan Kharazmi. The company has 1 employee. In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity amounted to DKK 24,221,286.